# Effect of Nilotinib in Cerebellar Ataxia Patients

> **NCT03932669** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 70 (actual)

## Conditions studied

- Ataxia, Cerebellar
- Ataxia, Progressive

## Interventions

- **DRUG:** Nilotinib

## Key facts

- **NCT ID:** NCT03932669
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-19
- **Primary completion:** 2020-08-13
- **Final completion:** 2020-08-13
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932669, "Effect of Nilotinib in Cerebellar Ataxia Patients". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03932669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*